Posttransplantation proteinuria: An approach to diagnosis and management

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 7, 2011, Pages 1786-1793

  Shamseddin, M Khaled ^a   Knoll, Greg A ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; RAMIPRIL; RAPAMYCIN;

ACCURACY; ACUTE GRAFT REJECTION; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC ALLOGRAFT NEPHROPATHY; DISEASE ASSOCIATION; DRUG EFFECT; GLOMERULONEPHRITIS; GLOMERULOPATHY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PATHOLOGY; POSTOPERATIVE COMPLICATION; POSTTRANSPLANTATION PROTEINURIA; PROGNOSIS; PROTEIN RESTRICTION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK; SURVIVAL; TREATMENT OUTCOME;

GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROTEINURIA; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 79960332507     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01310211     Document Type: Article

References (61)

1. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, Alberta Kidney Disease Network: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
2. Vassalotti JA, Stevens LA, Levey AS: Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 50: 169-180, 2007
3. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease Network: Using proteinuria and estimated glomerular filtration rate to classify risk on patients with chronic kidney disease. Ann Intern Med 154: 12-21, 2011
4. Morath C, Zeier M: When should post-transplantation proteinuria be attributed to the renal allograft rather than to the native kidney? Nat Clin Pract Nephrol 3: 18-19, 2007
5. Reichel H, Zeier M, Ritz E: Proteinuria after renal transplantation: Pathogenesis and management. Nephrol Dial Transplant 19: 301-305, 2004
6. Fernandez-Fresnedo G, Escallada R, Rodrigo E, De Francisco AL, Cotorruelo JG, Sanz De Castro S, Zubimendi JA, Ruiz JC, Arias M: The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 73: 1345-1348, 2002
7. Halimi JM, Matthias B, Al-Najjar A, Laouad I, Chatelet V, Marlière JF, Nivet H, Lebranchu Y: Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients. Am J Transplant 7: 2775-2781, 2007
8. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9: S1-S157, 2009
9. Amer H, Fidler ME, Myslak M, Morales P, Kremers WK, Larson TS, Stegall MD, Cosio FG: Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 7: 2748-2756, 2007
10. Roodnat JI, Mulder PG, Rischen-Vos J, van Riemsdijk IC, van Gelder T, Zietse R, IJzermans JN, Weimar W: Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 72: 438-444, 2001
11. Ibis A, Altunoglu A, Akgul A, Usluogullari CA, Arat Z, Ozdemir FN, Haberal M: Early onset proteinuria after renal transplantation: A marker for allograft dysfunction. Transplant Proc 39: 938-940, 2007
12. Sancho A, Gavela E, Avila A, Usluogullari CA, Arat Z, Oz-demir FN, Haberal M: Risk factors and prognosis for proteinuria in renal transplant recipients. Transplant Proc 39: 2145-2147, 2007
13. Halimi JM, Laouad I, Buchler M, Al-Najjar A, Chatelet V, Houssaini TS, Nivet H, Lebranchu Y: Early lowgrade proteinuria: Causes, short-term evolution and longterm consequences in renal transplantation. Am J Transplant 5: 2281-2288, 2005
14. Fernandez-Fresnedo G, Plaza JJ, Sanchez-Plumed J, Sanz-Guajardo A, Palomar-Fontanet R, Arias M: Proteinuria: A new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 19: 47-51, 2004
15. Chung J, Park SK, Park JS, Kim SC, Han DJ, Yu E: Glomerulonephritis is the major cause of proteinuria in renal transplant recipients: Histopathologic findings of renal allografts with proteinuria. Clin Transplant 14: 499-504, 2000
16. Karthikeyan V, Karpinski J, Nair RC, Knoll G: The burden of chronic kidney disease in renal transplant recipients. Am J Transplant 4: 262-269, 2004
17. Park JH, Park JH, Bok HJ, Kim BS, Yang CW, Kim YS, Kim SY, Moon IS, Koh YB, Bang BK: Persistent proteinuria as a prognostic factor for determining long-term graft survival in renal transplant recipients. Transplant Proc 32: 1924, 2000
18. Kim HC, Park SB, Lee SH, Park KK, Park CH, Cho WH: Proteinuria in renal transplant recipients: Incidence, cause, and prognostic importance. Transplant Proc 26: 2134-2135, 1994
19. Vathsala A, Verani R, Schoenberg L, Lewis RM, Van Buren CT, Kerman RH, Kahan BD: Proteinuria in cyclosporinetreated renal transplant recipients. Transplantation 49: 35-41, 1990
20. First MR, Vaidya PN, Maryniak RK, Weiss MA, Munda R, Fidler JP, Penn I, Alexander JW: Proteinuria following transplantation: Correlation with histopathology and outcome. Transplantation 38: 607-612, 1984
21. Yakupoglu U, Baranowska-Daca E, Rosen D, Barrios R, Suki WN, Truong LD: Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 65: 2360-2370, 2004
22. Akbari A, Hussain N, Karpinski J, Knoll GA: Chronic kidney disease management: Comparison between renal transplant recipients and nontransplant patients with chronic kidney disease. Nephron 107: c7-c13, 2007
23. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39: S1-S266, 2003
24. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomicbased detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15: 219-227, 2004
25. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005
26. Steinhauslin F, Wauters JP: Quantitation of proteinuria in kidney transplant patients: Accuracy of the urinary protein/creatinine ratio. Clin Nephrol 43: 110-115, 1995
27. Rodrigo E, Piñ era C, Ruiz JC, Fernández-Fresnedo G, Escallada R, Herráez I, Cotorruelo JG, Zubimendi JA, de Francisco AL, Sanz de Castro S, Arias M: Quantitation of 24-hour urine protein excretion in kidney transplant patients by the use of protein to creatinine ratio. Transplant Proc 35: 702, 2003
28. Torng S, Rigatto C, Rush DN, Nickerson P, Jeffery JR: The urine protein to creatinine ratio (P/C) as a predictor of 24-hour urine protein excretion in renal transplant patients. Transplantation 72: 1453-1456, 2001
29. D'Cunha PT, Parasuraman R, Venkat KK: Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation. Am J Transplant 5: 351-355, 2005
30. Myslak M, Amer H, Morales P, Fidler ME, Gloor JM, Larson TS, Stegall MD, Cosio FG: Interpreting post-transplant proteinuria in patients with proteinuria pretransplant. Am J Transplant 6: 1660-1665, 2006
31. Weir MR, Mulgaonkar S, Chan L, Shidban H, Waid TH, Preston D, Kalil RN, Pearson TC: Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: A randomized, controlled Spare-the-Nephron trial. Kidney Int December 29, 2010 [epub ahead of print]
32. Letavernier E, Pe'raldi MN, Pariente A, Morelon E, Legendre C: Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation 80: 1198-1203, 2005
33. Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED: Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation. Transplantation 82: 368-374, 2006
34. Amer H, and Cosio FG: Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 20: 2490-2492, 2009
35. Fontan MP, Rodriguez-Carmona A, Garcia FT, Valdes F: Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 67: 561-568, 1999
36. Fellstrom B, Holdaas H, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Staffler B, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators: Risk factors for reaching renal endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) Trial. Transplantation 79: 205-212, 2005
37. Knoll GA: Proteinuria in kidney transplant recipients: Prevalence, prognosis, and evidence-based management. Am J Kidney Dis 54: 1131-1144, 2009
38. Panek R, Lawen T, Kiberd BA: Screening for proteinuria in kidney transplant recipients. Nephrol Dial Transplant August 16 2010 [epub ahead of print]
39. Vogt L, Waanders F, Boomsma F, De Zeeuw D, Navis G: Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999-1007, 2008
40. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD Study Group: Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition-A patient-level meta-analysis. Ann Intern Med 139: 244-252, 2003
41. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
42. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860, 2001
43. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK, Avoid SI: Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 358: 2433-2446, 2008
44. Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R: Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. Hypertension 29: 744-750, 1997
45. Bianchi S, Bigazzi R, Campese VM: Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 70: 2116-2223, 2006
46. McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G: The effect of pentoxifylline on proteinuria in diabetic kidney disease: A meta-analysis. Am J Kidney Dis 52: 454-463, 2008
47. Kunz R, Friedrich C, Wolbers M, Mann JF: Meta analysis: Effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 148: 30-48, 2008
48. Salahudeen AK, Hostetter TH, Raatz SK, Rosenberg ME: Effects of dietary protein in patients with chronic renal transplant rejection. Kidney Int 41: 183-190, 1992
49. Biesenbach G, Zazgornik J, Janko O, Hubmann R, Syre G: Effect of mild dietary protein restriction on urinary protein excretion in patients with renal transplant fibrosis. Wien Med Wochenschr 146: 75-78, 1996
50. Cross NB, Webster AC, Masson P, O'Connell PJ, Craig JC: Antihypertensive treatment for kidney transplant recipients. Transplantation 88: 7-18, 2009
51. Shu KH, Wu MJ, Chen CH, Cheng CH, Lian JD, Lu YS: Effect of pentoxifylline on graft function of renal transplant recipients complicated with chronic allograft nephropathy. Clin Nephrol 67: 157-163, 2007
52. Morales JM, Marcén R, Andrés A, Molina MG, Castillo DD, Cabello M, Capdevila L, Campistol JM, Oppenheimer F, Serón D, Vernet SG, Lampreave I, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J: Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney Int (111): S94-S99, 2008
53. Dahlberg R, Muth B, Samaniego M, R. Hofmann M, Pirsch J, Djamali A: One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients. J Ren Nutr 20: 392-397, 2010
54. Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R: Angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17: 889-899, 2006
55. Opelz G, Zeier M, Lau G, Morath C, Dohler B: No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: A collaborative transplant study report. J Am Soc Nephrol 17: 3257-3262, 2006
56. Hiremath S, Fergusson D, Doucette S, Mulay AV, Knoll GA: Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence. Am J Transplant 7: 2350-2360, 2007
57. A double-blind, randomized placebo-controlled study to evaluate the renal protective effects of losartan in patients with renal transplants. Available at: www.clinicalstudyresults. org/home/. Accessed January 22, 2011
58. Campistol JM, Garcia DM, Alarcon A, et al.: Angiotensin II receptor blockage in kidney transplantation: Design and progress of the AALLOGRAFT study [Abstract 510]. World Transplant Congress, July 22-27, 2006, Boston, MA
59. Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, Lièvre M, Heemann U, Legendre C: Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: Results from SECRET. Nephrol Dial Transplant 25: 967-976, 2010
60. Amara AB, Sharma A, Alexander JL, Alfirevic A, Mohiuddin A, Pirmohamed M, Close GL, Grime S, Maltby P, Shawki H, Heyworth S, Shenkin A, Smith L, Sharma AK, Hammad A, Rustom R: Randomized controlled trial: Lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy. Transplantation 89: 104-114, 2010
61. Knoll GA, Cantarovitch M, Cole E, Gill J, Gourishankar S, Holland D, Kiberd B, Muirhead N, Prasad R, Tibbles LA, Treleaven D, Fergusson D: The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation-Study design. Nephrol Dial Transplant 23: 354-358, 2008